OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
OraSure Technologies, Inc. (NASDAQ: OSUR) has announced its upcoming earnings conference call for the second quarter of 2024. The call is scheduled for August 6, 2024, at 5 p.m. ET. Investors and interested parties can access the webcast through OraSure's investor relations website. The company will discuss its Q2 2024 financial results and provide updates on certain business developments during the call.
To participate and ask questions during the conference, attendees must pre-register using the provided link. The webcast will be archived on OraSure's website for approximately 90 days after the call. This announcement allows investors to prepare for the upcoming financial disclosure and gain insights into the company's recent performance and future outlook.
OraSure Technologies, Inc. (NASDAQ: OSUR) ha annunciato la sua prossima conference call sugli utili per il secondo trimestre del 2024. La chiamata è programmata per il 6 agosto 2024, alle 17:00 ET. Gli investitori e le parti interessate possono accedere alla webcast attraverso il sito web delle relazioni con gli investitori di OraSure. Durante la chiamata, l'azienda discuterà i risultati finanziari del Q2 2024 e fornirà aggiornamenti su alcuni sviluppi aziendali.
Per partecipare e porre domande durante la conferenza, i partecipanti devono preregistrarsi utilizzando il link fornito. La webcast sarà archiviata sul sito web di OraSure per circa 90 giorni dopo la chiamata. Questo annuncio consente agli investitori di prepararsi per la prossima divulgazione finanziaria e di ottenere approfondimenti sulle recenti performance dell'azienda e sulle prospettive future.
OraSure Technologies, Inc. (NASDAQ: OSUR) ha anunciado su próxima llamada de conferencia sobre ganancias para el segundo trimestre de 2024. La llamada está programada para el 6 de agosto de 2024, a las 5 p.m. ET. Los inversionistas y partes interesadas pueden acceder a la transmisión web a través del sitio web de relaciones con inversionistas de OraSure. La empresa discutirá los resultados financieros del Q2 2024 y proporcionará actualizaciones sobre ciertos desarrollos comerciales durante la llamada.
Para participar y hacer preguntas durante la conferencia, los asistentes deben preinscribirse utilizando el enlace proporcionado. La transmisión web se archivará en el sitio web de OraSure por aproximadamente 90 días después de la llamada. Este anuncio permite a los inversionistas prepararse para la próxima divulgación financiera y obtener información sobre el desempeño reciente de la empresa y su proyección futura.
OraSure Technologies, Inc. (NASDAQ: OSUR)는 2024년 2분기 실적 발표를 위한 컨퍼런스 콜을 발표했습니다. 이 콜은 2024년 8월 6일 오후 5시 ET에 예정되어 있습니다. 투자자와 관심 있는 당사자는 OraSure의 투자자 관계 웹사이트를 통해 웹캐스트에 접근할 수 있습니다. 회사는 콜 동안 2024년 2분기 재무 결과 및 특정 비즈니스 개발에 대한 업데이트를 논의할 것입니다.
컨퍼런스에 참여하고 질문을 하려면 참석자는 제공된 링크를 통해 사전 등록해야 합니다. 웹캐스트는 콜 이후 약 90일 동안 OraSure 웹사이트에 보관됩니다. 이 발표는 투자자들이 다가오는 재무 공시에 대비하고 회사의 최근 성과 및 향후 전망에 대한 통찰력을 얻을 수 있도록 합니다.
OraSure Technologies, Inc. (NASDAQ: OSUR) a annoncé sa prochaine conférence téléphonique sur les bénéfices pour le deuxième trimestre de 2024. L'appel est prévu pour le 6 août 2024 à 17h00 ET. Les investisseurs et parties intéressées peuvent accéder au webinaire via le site web des relations investisseurs d'OraSure. L'entreprise discutera des résultats financiers du Q2 2024 et fournira des mises à jour sur certains développements commerciaux lors de l'appel.
Pour participer et poser des questions pendant la conférence, les participants doivent s'inscrire à l'avance en utilisant le lien fourni. Le webinaire sera archivé sur le site d'OraSure pendant environ 90 jours après l'appel. Cette annonce permet aux investisseurs de se préparer à la prochaine divulgation financière et d'obtenir des informations sur les performances récentes de l'entreprise et ses perspectives futures.
OraSure Technologies, Inc. (NASDAQ: OSUR) hat seine bevorstehende Earnigns-Konferenz für das zweite Quartal 2024 angekündigt. Die Konferenz ist für den 6. August 2024 um 17 Uhr ET angesetzt. Investoren und interessierte Parteien können über die Investor-Relations-Website von OraSure auf das Webcast zugreifen. Das Unternehmen wird während des_calls die Finanzzahlen für Q2 2024 diskutieren und Updates zu bestimmten Geschäftsentwicklungen bereitstellen.
Um an der Konferenz teilzunehmen und Fragen zu stellen, müssen sich die Teilnehmer über den bereitgestellten Link vorab registrieren. Das Webcast wird etwa 90 Tage nach der Konferenz auf der Website von OraSure archiviert. Diese Ankündigung ermöglicht es den Investoren, sich auf die bevorstehende Finanzberichterstattung vorzubereiten und Einblicke in die jüngsten Leistungen des Unternehmens und die zukünftige Perspektive zu erhalten.
- None.
- None.
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.
For participants interested in asking questions during the conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.
https://register.vevent.com/register/BIe57bba25d853415d8352e2aa4f12a85a
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com
| Investor Contact: Jason Plagman VP, Investor Relations investorinfo@orasure.com | Media Contact: Amy Koch Director, Corporate Communications media@orasure.com |
FAQ
When is OraSure Technologies (OSUR) releasing its Q2 2024 earnings?
How can investors access OraSure's (OSUR) Q2 2024 earnings call?
What will be discussed during OraSure's (OSUR) Q2 2024 earnings call?
How long will the webcast of OraSure's (OSUR) Q2 2024 earnings call be available?
